Neurotechnology to take centre stage at the latest Horizon Deep Tech
Neurotechnology is opening up new possibilities for treating neurological disorders and functional recovery following brain injuries. These developments will be among the highlights of the Horizon Deep Tech Summit 2026, which will take place in Madrid from 10 to 12 November.
- Ander Ramos Murguialday, a researcher in medical technologies and an expert in neurotechnology, will share TECNALIA’s vision and the progress made in speeding up the transfer of these technologies into clinical practice and onto the market.
- He will be speaking at one of Europe’s leading events on deep tech, which brings together investors, start-ups, technology centres, corporations and institutions to take a look at the innovations that will transform strategic sectors such as healthcare, artificial intelligence, advanced computing and new materials.
Neurotechnology to transform people’s lives
TECNALIA will share some of the most significant advances that our healthcare team is developing to tackle neurological diseases and improve people’s quality of life using technologies that are capable of interacting directly with the nervous system.
- Our work focuses on developing neural interfaces and brain-machine interfaces, systems that are capable of reading and stimulating neural signals to diagnose, restore and improve neurological functions. These technologies have applications in fields such as rehabilitation after a stroke, Parkinson’s disease, spinal cord injuries and neurodegenerative diseases.
- We are working on bringing advanced neuroscience-based solutions to market, combining artificial intelligence, neural signal processing, brain stimulation and next-generation medical devices.
From brain-machine interfaces to neuromodulation of the future
The most recent developments include the Neumonas initiative, led by TECNALIA, which has demonstrated the feasibility of a new generation of non-invasive neuromodulation tools for conditions such as stroke and Parkinson’s disease. The technology uses nanoparticles that can cross the blood-brain barrier and target specific groups of neurons using light and magnetic fields, paving the way for more precise, less invasive treatments.
TECNALIA’s neurotechnology team is also researching solutions based on brain-machine interfaces to aid the functional recovery of patients with neurological damage, making it possible to harness the brain’s plasticity to restore lost movements and abilities.
Basque innovation on the European stage
TECNALIA’s presence at the Horizon Deep Tech Summit reinforces the centre’s position as one of Europe’s leading players in neurotechnology and digital health.
- As well as showcasing scientific and technological advances with the potential to have a clinical and industrial impact, the event will help strengthen partnerships with companies, investors and international organisations that are keen to speed up the market launch of new deep tech solutions.
- We will highlight the role of neurotechnology as one of the fields with the greatest potential to transform medicine in the coming years, by driving more personalised, precise, effective treatments to tackle some of the greatest health challenges facing our society.
Horizon Deep Tech is backed by the European innovation ecosystem, with support from organisations such as the European Innovation Council (EIC) and CDTI, and is establishing itself as a leading hub for speeding up technology transfer and creating new business opportunities based on science and technology.